Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALPG | P10696 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13321940 | 0.98 | GAA (0.53) | SMN1; SMN2GAAKCNA5CA2CA4 | |
| SCHEMBL28318624 | 0.93 | SMN1; SMN2 (0.53) | SMN1; SMN2GAAKCNA5CA2CA4 | |
| SCHEMBL20195697 | 0.89 | HPGD (0.44) | SMN1; SMN2GAAKCNA5HPGDCYP3A4 | |
| SCHEMBL10426380 | 0.89 | SMN1; SMN2 (0.52) | SMN1; SMN2GAAKCNA5CA2CA4 | |
| SCHEMBL7930260 | 0.85 | SMN1; SMN2 (0.44) | SMN1; SMN2GAAKCNA5 | |
| SCHEMBL778386 | 0.83 | SMN1; SMN2 (0.43) | SMN1; SMN2GAACA2CA4CA5A | |
| SCHEMBL9927225 | 0.83 | SMN1; SMN2 (0.47) | SMN1; SMN2GAAKCNA5CA2CA4 | |
| SCHEMBL778410 | 0.82 | GAA (0.41) | SMN1; SMN2GAAKCNA5CA2CA4 | |
| SCHEMBL11991127 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2GAAKCNA5ALDH1A1 | |
| SCHEMBL24817133 | 0.81 | SMN1; SMN2 (0.42) | SMN1; SMN2GAAKCNA5CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4108706-B1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | SHINETSU CHEMICAL CO (JP) | 2025-09-10 | — | — | EP | claimed |
| CN-118406027-A | Preparation method of trans-2, 5-dimethyl tetrahydrofuran | 南昌大学 | 2024-07-30 | — | — | CN | claimed |
| CN-115135698-B | Process for producing cyclic polysiloxane | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | claimed |
| CN-115608359-B | Copper catalyst and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2024-04-05 | — | — | CN | claimed |
| CN-117085698-A | Mercury-free catalyst with ultralow noble metal content for hydrochlorination of acetylene and preparation method thereof | 中国科学院大连化学物理研究所 | 2023-11-21 | — | — | CN | claimed |
| CN-115873402-A | Heat-resistant master batch and heat-stable polyamide composition thereof | 华峰集团有限公司 | 2023-03-31 | — | — | CN | claimed |
| US-20230095953-A1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-03-30 | — | — | US | claimed |
| CN-115608359-A | Copper catalyst and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2023-01-17 | — | — | CN | claimed |
| EP-4108706-A1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-12-28 | — | — | EP | claimed |
| CN-115135698-A | Method for producing cyclic polysiloxane | 信越化学工业株式会社 | 2022-09-30 | — | — | CN | claimed |
| US-10815258-B2 | Phosphine oxides reduction | RHODIA OPERATIONS (FR) | 2020-10-27 | — | — | US | claimed |
| US-20200231613-A1 | PHOSPHINE OXIDES REDUCTION | SPECIALTY OPERATIONS FRANCE (FR) | 2020-07-23 | — | — | US | claimed |
| US-4155932-A | REACTING CHLORINE AND CARBON MONOXIDE WITH A TERTIARY PHOSPHINE OXIDE | UBE INDUSTRIES, INC. (JP) | 1979-05-22 | — | — | US | claimed |
| EP-4108706-B1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | SHINETSU CHEMICAL CO (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| CN-119101083-A | Preparation method and application of cuprous halide-based fluorescent light-emitting material | 华东师范大学 | 2024-12-10 | — | — | CN | disclosed |
| US-20060133978-A1 | Method of making crystalline inorganic particles | GENERAL ELECTRIC COMPANY | 2006-06-22 | — | — | US | disclosed |
| US-20040253174-A1 | Method of making oxide particles | GENERAL ELECTRIC COMPANY | 2004-12-16 | — | — | US | disclosed |
| US-4845306-A | PHOSPHINE-RHODIUM CATALYSTS, HYDROFORMYLATION REACTIONS | EASTMAN KODAK COMPANY (US) | 1989-07-04 | — | — | US | disclosed |
| US-4155932-A | REACTING CHLORINE AND CARBON MONOXIDE WITH A TERTIARY PHOSPHINE OXIDE | UBE INDUSTRIES, INC. (JP) | 1979-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815258-B2 | Phosphine oxides reduction | PHOSPHO1, PSPH, PTEN | SMN1; SMN2 2237/4885GAA 4214/4885KCNA5 3691/4885 |
| US-20230095953-A1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | POLL, PCNA, RPN1 | SMN1; SMN2 4365/4885GAA 3821/4885KCNA5 2475/4885 |
| US-20200231613-A1 | PHOSPHINE OXIDES REDUCTION | PHOSPHO1, PSPH, PTEN | SMN1; SMN2 2237/4885GAA 4214/4885KCNA5 3691/4885 |
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | SMN1; SMN2 3862/4885GAA 2692/4885KCNA5 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.